ARCHIVES

MGI Pharma, MethylGene Begin Phase II Trial Of MG98.

This article is from The Cancer Letter archive.

Vol. 27 No. 35 | September 28, 2001

Download PDF Visit The Full Archive

Related Articles

Cancer Act Doesn’t Require Geographic Distribution Of Comp Centers

March 4, 1977

Meharry, Vanderbilt Win Grant For Research Collaboration.

March 30, 2001

Survey Commissioned By Cancer Control Program Finds Important RMP Effort Being Phased Out

July 19, 1974

NCI-Approved Clinical Trials Listed For January

January 28, 2005

Hawkins Calls For Joins Cancer Center-Community Effort To Develop Better Technology Transfers

May 29, 1981

RFP To Be Issued For Two More Neutron Therapy Facilities; Winners To Conduct Clinical Trials

October 27, 1978